TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Bionomit Public AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
8
|
41
|
1 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-62
|
0
|
-2,202 |
| EBITDA |
-62
|
0
|
-35 |
| Total assets |
3,191
|
3,334
|
3,302 |
| Current assets |
58
|
64
|
32 |
| Current liabilities |
95
|
68
|
65 |
| Equity capital |
3,072
|
3,241
|
3,206 |
| - share capital |
325
|
336
|
334 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
96.3%
|
97.2%
|
97.1% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-775.0%
|
0%
|
-220200% |
| Return on assets (ROA) |
-1.9%
|
0%
|
-66.7% |
| Current ratio |
61.1%
|
94.1%
|
49.2% |
| Return on equity (ROE) |
-2.0%
|
0%
|
-68.7% |
| Change turnover |
-31
|
40
|
-1 |
| Change turnover % |
-79%
|
6000%
|
-50% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.